JOURNAL ARTICLE

King's College London Reports Findings in Headache (Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study).

  • Published In: Psychology & Psychiatry Journal, 2024. P. 157 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

A recent study conducted by King's College London explored the effects of low-dose psilocybin, a psychedelic compound, on patients with short-lasting unilateral neuralgiform headache attacks (SUNHA). The study aimed to assess the safety, tolerability, and effects on headache severity and frequency. However, the study was terminated early due to recruitment difficulties, with only four patients enrolled. While no significant adverse events were recorded, the study did not provide conclusive evidence for the use of psilocybin in treating SUNHA. The researchers suggest that psychological factors may play a crucial role in the treatment of chronic SUNHA. [Extracted from the article]

Additional Information

  • Source:Psychology & Psychiatry Journal. 2024/10, p157
  • Document Type:Article
  • Subject Area:Complementary and Alternative Medicine
  • Publication Date:2024
  • ISSN:1944-2718
  • Accession Number:179931347
  • Copyright Statement:Copyright of Psychology & Psychiatry Journal is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.